Parental Preferences Regarding the Novel Systemic Treatment for Atopic Dermatitis in Children
Keywords:
atopic dermatitis, monoclonal antibodies, dupilumab, the Janus kinase inhibitorsReferences
Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999;103(1):125-138. doi:https://doi.org/10.1016/S0091-6749(99)70536-1
Ervin C, Crawford R, Evans E, et al. Patient and caregiver preferences on treatment attributes for atopic dermatitis. https://doi.org/101080/0954663420211940810. 2021;33(4):2225-2233. doi:10.1080/09546634.2021.1940810
de Wijs LEM, van Egmond S, Devillers ACA, et al. Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study. Arch Dermatol Res. 2022;315(1):75-83. doi:10.1007/S00403-021-02321-Z/TABLES/1
Kajikawa N, Maeno T, Maeno T. Does a child’s fear of needles decrease through a learning event with needles? Issues Compr Pediatr Nurs. 2014;37(3):183-194. doi:10.3109/01460862.2014.942443
Boland L, Kryworuchko J, Saarimaki A,et al. Parental decision making involvement and decisional conflict: A descriptive study. BMC Pediatr. 2017;17(1):1-8. doi:10.1186/S12887-017-0899-4/TABLES/3
Published
Issue
Section
License
Copyright (c) 2024 Alicja Mesjasz, Monika Łobaza, Marta Jaskulak, Magdalena Trzeciak
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.